Results 321 to 330 of about 589,865 (354)

Immunohistochemical study of non-Hodgkin lymphoma patients in Basrah (Single center experience)

open access: gold
Haider Abdul Hassan Ali   +2 more
openalex   +1 more source

The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma. [PDF]

open access: yesBlood Cancer J
Dingli S   +14 more
europepmc   +1 more source

Supplementary Figure S3 from A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma

open access: gold
Paolo Strati   +18 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management

American journal of hematology/oncology, 2022
Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid malignancy affecting 8540 new patients annually and representing approximately 10% of all lymphomas in the United States.
S. Ansell
semanticscholar   +1 more source

Hodgkin lymphoma

Medicine, 2018
This edition describes the increased use of PET scanning in staging and follow-up. Chapters discuss current treatment options—including combination chemotherapy, radiation therapy, novel treatment techniques, and hematopoietic stem cell transplantation ...
D. Wrench, Paul Fields
semanticscholar   +1 more source

Non-Hodgkin lymphoma

British medical journal, 2018
### What you need to know Non-Hodgkin lymphoma are malignant disorders arising from cells of the immune system, and manifest predominantly as lymphadenopathy or solid tumours. The classification of non-Hodgkin lymphoma is complex and ever-evolving, with
Anna Bowzyk Al-Naeeb   +3 more
semanticscholar   +1 more source
oncology
biology
chemotherapy
immunology
pathology
gastroenterology
surgery
physics
non-hodgkin lymphoma
previous   31  32  33  34  35  36  

Home - About - Disclaimer - Privacy